Log in to save to my catalogue

Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury

Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0021957feb484ccdac2aff962e27ea4a

Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury

About this item

Full title

Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury

Publisher

Basel: MDPI AG

Journal title

Antioxidants, 2021-08, Vol.10 (9), p.1329

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Cisplatin is a chemotherapy agent commonly used to treat a wide variety of cancers. Despite the potential for both severe acute and chronic side effects, it remains a preferred therapeutic option for many malignancies due to its potent anti-tumor activity. Common cisplatin-associated side-effects include acute kidney injury (AKI) and chronic kidney...

Alternative Titles

Full title

Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0021957feb484ccdac2aff962e27ea4a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0021957feb484ccdac2aff962e27ea4a

Other Identifiers

ISSN

2076-3921

E-ISSN

2076-3921

DOI

10.3390/antiox10091329

How to access this item